` OFSA3 (Ouro Fino Saude Animal Participacoes SA) vs BOVESPA Comparison - Alpha Spread

OFSA3
vs
BOVESPA

Over the past 12 months, OFSA3 has underperformed BOVESPA, delivering a return of -12% compared to the BOVESPA's 3% growth.

Stocks Performance
OFSA3 vs BOVESPA

Loading

Performance Gap
OFSA3 vs BOVESPA

Loading
OFSA3
BOVESPA
Difference

Performance By Year
OFSA3 vs BOVESPA

Loading
OFSA3
BOVESPA
Add Stock

Competitors Performance
Ouro Fino Saude Animal Participacoes SA vs Peers

BOVESPA
OFSA3
LLY
JNJ
NOVO B
ROG
Add Stock

Ouro Fino Saude Animal Participacoes SA
Glance View

Market Cap
1.2B BRL
Industry
Pharmaceuticals

Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.

OFSA3 Intrinsic Value
51.31 BRL
Undervaluation 57%
Intrinsic Value
Price
Back to Top